Sanli Y - Search Results

1

Timing and Impact of Posttreatment PET/CT After First 6 Months on Patient Management and Outcomes in Oropharyngeal Squamous Cell Carcinoma.

You H, Xi Y, Moore W, Sher D, Sanli Y, Subramaniam RM. You H, et al. Among authors: sanli y. AJR Am J Roentgenol. 2019 May;212(5):1142-1147. doi: 10.2214/AJR.18.20619. Epub 2019 Mar 5. AJR Am J Roentgenol. 2019. PMID: 30835513

2

The inferior performance of [⁶⁸Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [¹⁷⁷Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors.

Has Simsek D, Guzel Y, Denizmen D, Sanli Y, Buyukkaya F, Kovan B, Komek H, Isik EG, Ozkan ZG, Kuyumcu S. Has Simsek D, et al. Among authors: sanli y. Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):828-840. doi: 10.1007/s00259-023-06497-6. Epub 2023 Nov 10. Eur J Nucl Med Mol Imaging. 2024. PMID: 37947850

3

FAPI-Negative FDG-Avid Metastatic Relapse of Breast Cancer on PET/CT.

Civan C, Has Simsek D, Isik EG, Sanli Y, Kuyumcu S. Civan C, et al. Among authors: sanli y. Clin Nucl Med. 2023 Aug 1;48(8):e380-e381. doi: 10.1097/RLU.0000000000004704. Epub 2023 May 23. Clin Nucl Med. 2023. PMID: 37220240

4

An anthropomorphic body phantom for the determination of calibration factor in radionuclide treatment dosimetry.

Kovan B, Demir B, Işık EG, Has Şimşek D, Özkan ZG, Kuyumcu S, Türkmen C, Şanlı Y. Kovan B, et al. Among authors: sanli y. Radiat Prot Dosimetry. 2023 Jul 21;199(12):1274-1283. doi: 10.1093/rpd/ncad176. Radiat Prot Dosimetry. 2023. PMID: 37334429 Free PMC article.

5

A multi-institutional assessment of eye lens dose in nuclear medicine clinics.

Abuqbeitah M, Demir M, Işikci NI, Kozanlilar B, Kovan B, Yeyin N, Fikret Çermik T, Şanli Y, Sönmezoğlu K. Abuqbeitah M, et al. Among authors: sanli y. Nucl Med Commun. 2023 Sep 1;44(9):772-776. doi: 10.1097/MNM.0000000000001727. Epub 2023 Jul 18. Nucl Med Commun. 2023. PMID: 37464817

6

Precision Medicine and PET-Computed Tomography in Pediatric Malignancies.

Sanli Y, Yilmaz E, Subramaniam RM. Sanli Y, et al. PET Clin. 2017 Oct;12(4):423-435. doi: 10.1016/j.cpet.2017.05.009. Epub 2017 Jul 28. PET Clin. 2017. PMID: 28867113 Review.

7

Precision Medicine and PET/Computed Tomography in Melanoma.

Mena E, Sanli Y, Marcus C, Subramaniam RM. Mena E, et al. Among authors: sanli y. PET Clin. 2017 Oct;12(4):449-458. doi: 10.1016/j.cpet.2017.05.002. Epub 2017 Jul 14. PET Clin. 2017. PMID: 28867115 Free PMC article. Review.

8

Neuroendocrine Tumor Diagnosis and Management: ⁶⁸Ga-DOTATATE PET/CT.

Sanli Y, Garg I, Kandathil A, Kendi T, Zanetti MJB, Kuyumcu S, Subramaniam RM. Sanli Y, et al. AJR Am J Roentgenol. 2018 Aug;211(2):267-277. doi: 10.2214/AJR.18.19881. Epub 2018 Jul 5. AJR Am J Roentgenol. 2018. PMID: 29975116 Review.

9

68Ga-PSMA PET/CT and PET/MRI in high-risk prostate cancer patients.

Sanli Y, Sanli O, Has Simsek D, Subramaniam RM. Sanli Y, et al. Among authors: sanli o. Nucl Med Commun. 2018 Oct;39(10):871-880. doi: 10.1097/MNM.0000000000000888. Nucl Med Commun. 2018. PMID: 30124601 Review.

10

Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.

Sanli Y, Zukotynski K, Mittra E, Chen DL, Nadel H, Niederkohr RD, Subramaniam RM. Sanli Y, et al. Clin Nucl Med. 2018 Dec;43(12):e439-e452. doi: 10.1097/RLU.0000000000002247. Clin Nucl Med. 2018. PMID: 30394934 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters